|
KMID : 0366220170520040254
|
|
Korean Journal of Hematology
2017 Volume.52 No. 4 p.254 ~ p.263
|
|
|
Management of immune thrombocytopenia: Korean experts recommendation in 2017
|
|
Jang Jun-Ho
Kim Ji-Yoon
Mun Yeung-Chul
Bang Soo-Mee
Lim Yeon-Jung
Shin Dong-Yeop
Choi Young-Bae
Yhim Ho-Young
Lee Jong-Wook
Kook Hoon
|
|
|
Abstract
|
|
|
|
Management options for patients with immune thrombocytopenia (ITP) have evolved substantially over the past decades. The American Society of Hematology published a treatment guideline for clinicians referring to the management of ITP in 2011. This evi-dence-based practice guideline for ITP enables the appropriate treatment of a larger pro-portion of patients and the maintenance of normal platelet counts. Korean authority oper-ates a unified mandatory national health insurance system. Even though we have a uni-form standard guideline enforced by insurance reimbursement, there are several un-solved issues in real practice in ITP treatment. To optimize the management of Korean ITP patients, the Korean Society of Hematology Aplastic Anemia Working Party (KSHAAWP) reviewed the consensus and the Korean data on the clinical practices of ITP therapy. Here, we report a Korean expert recommendation guide for the management of ITP.
|
|
|
KEYWORD
|
|
|
Aplastic Anemia Working Party, ITP, Recommendation, Management
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|